Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alternative RNA Splicing02:18

Alternative RNA Splicing

27.2K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
27.2K
Alternative RNA Splicing02:18

Alternative RNA Splicing

5.6K
5.6K
RNA Splicing01:32

RNA Splicing

61.8K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
61.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Myc sustains sex-biased organ zonation in the Drosophila intestine.

Developmental cell·2026
Same author

Monocarboxylate transporter 2 regulates maintenance of myelin and axonal integrity by oligodendrocytes.

Nature communications·2026
Same author

Integrated lipidome and miRNome analyses reveal sex-based differences in circulating extracellular vesicles of alcohol use disorder patients.

Cell biology and toxicology·2026
Same author

Liquid Biopsy in Advanced Prostate Cancer.

Cancers·2026
Same author

The need to increase support for healthy ageing and longevity research in the EU by establishing a Coordination and Support Programme on Healthy Ageing and Longevity.

Mechanisms of ageing and development·2026
Same author

Transcriptomic meta-analysis identifies core molecular pathways in plaque psoriasis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Related Experiment Video

Updated: Apr 14, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

9.5K

BRCA1 Alternative splicing landscape in breast tissue samples.

Atocha Romero1,2,3, Francisco García-García4,5, Irene López-Perolio6,7

  • 1Molecular Oncology Laboratoy, Instituto de Investigación Sanitaria San Carlos. Center affiliated to the Red Temática de Investigación Cooperativa (RD12/0036/006), Instituto Carlos III, Spanish Ministry of Economy and Competitivy, 28040, Madrid, Spain. atocha10@hotmail.com.

BMC Cancer
|April 18, 2015
PubMed
Summary

BRCA1 alternative splicing (AS) patterns are similar in breast and blood tissues, with no evidence of tissue-specific events. While BRCA1 AS is complex, it rarely drives breast cancer through somatic mutations.

More Related Videos

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

12.8K
Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
09:22

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

6.1K

Related Experiment Videos

Last Updated: Apr 14, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

9.5K
gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

12.8K
Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
09:22

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

6.1K

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • BRCA1 protein is crucial for DNA repair and cell cycle regulation.
  • Previous studies identified numerous BRCA1 alternative splicing (AS) events in blood.
  • BRCA1 splicing patterns in breast tissue remained largely uncharacterized.

Purpose of the Study:

  • To accurately describe the distribution and characteristics of BRCA1 splicing events in breast tissue.
  • To compare BRCA1 AS patterns between breast tumor, normal breast, and blood samples.
  • To investigate the potential role of BRCA1 AS in breast carcinogenesis.

Main Methods:

  • BRCA1 splicing events were analyzed in 70 breast tumor, 4 normal breast, and 72 blood samples.
  • Capillary electrophoresis was employed to scan for splicing variations.
  • Predominant splicing events were defined as those with at least 10% relative expression.

Main Results:

  • 54 BRCA1 AS events were identified, with 27 being predominant in at least one sample.
  • Specific events (e.g., Δ5q, Δ13) were more frequent in breast tumors than in blood.
  • Likely inactivating BRCA1 AS events were more common in tumor samples than normal breast tissue.

Conclusions:

  • BRCA1 AS complexity is similar in breast and blood, with no tissue-specific events observed.
  • Somatic inactivation of BRCA1 via spliciogenic mutations is a rare mechanism in breast cancer.
  • An excess of likely inactivating AS events was detected in breast tumor samples.